One of the advantages of the device RIKTA is its timer with biological individualized exposure time standards. Velocity of biological processes is individual; it depends on the sign of misbalance of energy supply of the registered process. Subjective biological time of a person depends on the proportion of his sympathetic and parasympathetic tonus at the moment.
An increase of parasympathetic tonus accelerates individual biological time (the period of 40-50 sec registered by a physical clock seems to last 1 minute to an individual). Accordingly, an increase of parasympathetic tonus delays this time. The emotional factor and a hormonal background, accordingly, are also able to change abruptly the velocity of neuropsychic, somatic processes of the organism and structural - metabolic and functional processes on the tissular, cellular and sub-cellular level. An hour passed in a queue and an hour passed at a concert of your favorite artiste would be biologically different while.
The use of the biological timer in the biocontrolled chronotherapy accelerates the formation of tissular memory. In that case the elaboration of conditioned reflex of capillary network reaction to a patient's respiration, when quantum action amplifies, accelerates, and strength of the reflex grows. The use of the biological timer in the treatment of parodontosis allowed observing an increase of remission period of the patients at least by a month (S.Zaguskin and others, 1990). The normalization of microcirculation rhythm spectrum has been obtained faster as compared with the same procedure using a physical timer.
The device RIKTA has a number of peculiarities. It uses, instead of fixed frequencies of emission, the signals from the pulse and respiration sensors containing a wide set of blood flow rhythms. The influence of the device RIKTA is realized automatically in synchronism with changes of these rhythms of the patient, and is enhanced only during favorable moments of a high blood saturation of tissue, when energy resources of active cell responses are increased. According to the pathology character (kind of disease), the user has to set, instead of a fixed frequency, one of 4 modes of treatment characterized by different ratio of depth of modulation by signals from pulse, respiration and tremor sensors (varying frequency 7–13 Hz). Carrier frequency in this device is always 22,5 kHz; it corresponds to the maximum of singlet oxygen production and gives a deeper penetration of emission into tissue.
Instead of timer measuring in minutes, it is possible to use in this device a biotimer, counting the exposure time for each area by number of intervals between ticks of the blood. Counting by number of heart sounds (ticks of the blood), that is, biological units, allows standardizing the real duration of a therapeutic influence independently of the patient's condition, to elaborate the tissular memory more quickly and to assure a more stable therapeutic effect.
The emission power of the device RIKTA is not regulated, because it is rational to use always the maximum power, with mean power density 1 mWt/cm2. The irradiation dose for children is reduced due to a 2-4 times lesser exposure time (60 heart beats (HB) instead of 120 HB or 240 HB). The therapeutic range in the mode of biocontrol realized by the device RIKTA is amplified. The weaker influences become effective, and the stronger ones provoke neither overdose not exacerbation which were possible with these intensities in usual physiotherapy.
Biocontrol mode based on patient's biorhythms excludes a habituation and adaptation, because heartbeats and respiration periods are constantly varying. Only this biocontrol mode of the device RIKTA allows not only restore the microcirculation level at the place of pathology but also microcirculation rhythm spectrum, thereby providing for normalization of tissular trophicity, regeneration quality improvement and so on. A systematic character of treatment, the harmonization of all functional systems and biorhythms of the organism could be achieved due to the coordination of the local and central blood flow.
Another important peculiarity of the device RIKTA is a possibility to make a fast estimation of the patient's response to the therapeutic influence. It is recommended to register the pulse and respiration rates of a patient, as well as the ratio pulse rate / respiration rate, before, during and after a therapeutic procedure. In case of a jump of the pulse rate, or if the pulse / respiration ratio exceeds 7-9 or, on the contrary, falls to 2 and less, the séance must be interrupted. Subsequent séances are to be carried out excluding the zones the reaction of which to the irradiation has manifested initial signs of negative effect (worsening of pulse/respiration ratio). If the reaction is normal and the ration is maintained at the level 3-5 or at the same level as before the procedure, or on the contrary, if this ration is approaching the normal range of 3-5 incident to a healthy man, then the subsequent séances should be repeated in the same mode using the same zones as indicated in the Methodical Recommendations.
The device RIKTA-05 can be used in veterinary for treatment of cows, sheep, dogs, cats. Pulse sensor is fixed to an ear or the tail of the animal.
Methodical Recommendations elaborated for other quantum therapy device are fully applicable for the device RIKTA, too. The only difference is that instead of a fixed frequency of emission, one of the four modes of biocontrol should be used. For children's treatment the exposure on every zone is 2 times shorter. A usual physical timer can be used in the device, too, even though to treat the diseases indicated in the corresponding methods we recommend counting the exposure time by the number of pulse beats: we take 1 minute of irradiation as 60 pulse beats, 2 min. as 120 pulse beats, 3 min. as 180 pulse beats, 4 min. as 240 pulse beats, 5 min. as 300 pulse beats.
The patient's reaction to a quantum therapy séance by the device RIKTA can be appreciated by the change of pulse rate, respiration rate and, the most important, by a chronobiological index which has been used a long time ago in "oriental" medical practice: pulse rate / respiration rate ratio. One considers the effect as positive if this index is maintained or approaches to the range 3 - 5. Going out off these limits at the initial state, before the séance, evidences the presence of "hot" or "cold" (according to the oriental terminology) diseases. If this index becomes lower than 3 or higher than 5 during the séance, it is necessary to interrupt the procedure and make a one-day break, or to change the time of the séance.
To normalize neurohumoral regulation of the organs with parasympathetic excitation (small pelvis organs, urological diseases), therapeutic séances have to be realized at the period of preponderance of sympathetic tonus, that is, before noon. For the organs with sympathetic excitation or for normalization of hemodynamics disturbances, cerebral blood flow disturbances and treatment of cardiovascular affections, the séances should be better realized in the afternoon when parasympathetic tonus dominates. It has been observed during balneological cure of cardiovascular diseases that a séance at 13-16 o'clock has a positive effect, and the same séance in the morning could lead to negative consequences (I.Oransky, 1988). However, we should note that some pathologies are accompanied by changes of individual daily rhythms as compared with the normal ones, that's why an interactive mode of simultaneous chronodiagnostics is required.
The quantum therapy device with biocontrol RIKTA is a therapeutic and diagnostic instrument of a new generation. It accumulates the newest achievements of quantum therapy and can be recommended for prophylaxis and treatment of a wide rage of diseases, especially of the patients with low reserves of homeostasis, children and elderly people and complicated pathologies with accompanying diseases. The realization by the device RIKTA in the interactive mode of chronodiagnostics and biocontrolled quantum therapy methods opens new possibilities for an individual optimization and a guaranteed therapeutic effect achievement.
